Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.
PKI Solutions is proud to announce the integration of the PKI Maturity Model Self-Assessment from the PKI Consortium into PKI Spotlight, the cutting-edge platform for real-time Public Key ...
Lookout, Inc., the data-centric cloud security company, today announced new features for its Mobile Threat Defense (MTD) solution, Lookout Mobile Endpoint Security. These advancements provide ...